XML 121 R22.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SCHEDULE OF DISAGGREGATED REVENUE

For the years ended December 31, 2022 and 2021, the Company had the following disaggregated revenue:

 

   Year Ended December 31, 
   2022   %   2021   % 
                 
Telehealth revenue  $82,649,845    69%  $68,197,128    73%
WorkSimpli revenue   36,383,675    31%   24,678,678    27%
Total net revenue  $119,033,520    100%  $92,875,806    100%
SCHEDULE OF CONTRACT WITH CUSTOMER LIABILITY

The Company records deferred revenues when cash payments are received or due in advance of its performance. The Company’s deferred revenues relate to the following: (1) obligations for products which the customer has not yet obtained control due to delivery not commensurate upon shipment of the product, (2) obligations on WorkSimpli in-process monthly or yearly contracts with customers and (3) a portion attributable to the yet to be recognized WorkSimpli initial 14-day trial period collections.

 

   2022   2021 
   Year Ended December 31, 
   2022   2021 
Beginning of period  $1,499,880   $916,880 
Additions   37,410,617    23,430,037 
Revenue recognized   (33,362,991)   (22,847,037)
End of period  $5,547,506   $1,499,880 
SUMMARY OF INVENTORY

As of December 31, 2022 and 2021, the Company’s inventory consisted of the following:

 

   2022   2021 
   December 31, 
   2022   2021 
         
Finished Goods - Products  $2,587,370   $1,592,654 
Raw materials and packaging components   1,276,891    81,427 
Inventory reserve   (160,898)   (57,481)
Total Inventory - net  $3,703,363   $1,616,600 
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

The following table summarizes the number of shares of common stock issuable pursuant to our convertible securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise price could be less than the average market price of the common shares:

 

    2022     2021  
    Year Ended December 31,  
    2022     2021  
             
Series B Convertible Preferred Stock     1,404,868       1,264,868  
Restricted Stock Units (RSUs)     1,743,250       975,375  
Stock options     3,758,920       4,257,233  
Warrants     3,859,638       3,888,438  
Potentially dilutive securities     10,766,676       10,385,914